News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Sees Safety Issue with Merck & Co., Inc. (MRK) Hepatitis Drug



4/25/2011 8:21:00 AM

Reuters -- U.S. drug reviewers highlighted safety issues with an experimental Merck & Co hepatitis drug, including anemia and reports of psychiatric problems, in documents released on Monday.

A Food and Drug Administration advisory panel will review the potential blockbuster drug, boceprevir, at a public meeting on Wednesday. FDA staff said they generally agreed with Merck's assessment that boceprevir was effective in treating hepatitis C, a disease that destroys the liver.


Read at Reuters
Read at Nasdaq


comments powered by Disqus
Reuters
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES